Cargando…

Blinding Trachoma: Systematic Review of Rates and Risk Factors for Progressive Disease

BACKGROUND: Sight loss from trachoma is the end result of a scarring disease process starting in early childhood and characterised by repeated episodes of conjunctival inflammation (active trachoma). Subsequently, the conjunctiva becomes scarred, causing the eyelashes to turn inwards and scratch the...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramadhani, Athumani M., Derrick, Tamsyn, Holland, Martin J., Burton, Matthew J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4970760/
https://www.ncbi.nlm.nih.gov/pubmed/27483002
http://dx.doi.org/10.1371/journal.pntd.0004859
_version_ 1782446010328416256
author Ramadhani, Athumani M.
Derrick, Tamsyn
Holland, Martin J.
Burton, Matthew J.
author_facet Ramadhani, Athumani M.
Derrick, Tamsyn
Holland, Martin J.
Burton, Matthew J.
author_sort Ramadhani, Athumani M.
collection PubMed
description BACKGROUND: Sight loss from trachoma is the end result of a scarring disease process starting in early childhood and characterised by repeated episodes of conjunctival inflammation (active trachoma). Subsequently, the conjunctiva becomes scarred, causing the eyelashes to turn inwards and scratch the cornea (trichiasis), damaging the corneal surface and leading to corneal opacification and visual impairment. It is thought that this process is initiated and driven by repeated infection with Chlamydia trachomatis. We review published longitudinal studies to re-examine the disease process, its progression rates and risk factors. METHODOLOGY/PRINCIPAL FINDINGS: We searched PubMed for studies presenting incidence and progression data for the different stages of trachoma natural history. We only included studies reporting longitudinal data and identified 11 publications meeting this criterion. The studies were very heterogeneous in design, disease stage, duration, size and location, precluding meta-analysis. Severe conjunctival inflammation was consistently associated with incident and progressive scarring in five studies in which this was examined. One study reported an association between C. trachomatis infection and incident scarring. No studies have yet demonstrated an association between C. trachomatis infection and progressive scarring. Several studies conducted in regions with low prevalence active disease and C. trachomatis infection found evidence of on-going scarring progression. CONCLUSIONS/SIGNIFICANCE: Overall, there are few longitudinal studies that provide estimates of progression rates and risk factors, reflecting the challenges of conducting such studies. Our understanding of this disease process and the long-term impact of control measures is partial. Intense conjunctival inflammation was consistently associated with scarring, however, direct evidence demonstrating an association between C. trachomatis and progression is limited. This suggests that on-going chlamydial reinfection may not be mandatory for progression of established scarring, indicating that sight threatening trichiasis may continue to evolve in older people in formerly endemic populations, that will require service provision for years after active disease is controlled.
format Online
Article
Text
id pubmed-4970760
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-49707602016-08-18 Blinding Trachoma: Systematic Review of Rates and Risk Factors for Progressive Disease Ramadhani, Athumani M. Derrick, Tamsyn Holland, Martin J. Burton, Matthew J. PLoS Negl Trop Dis Research Article BACKGROUND: Sight loss from trachoma is the end result of a scarring disease process starting in early childhood and characterised by repeated episodes of conjunctival inflammation (active trachoma). Subsequently, the conjunctiva becomes scarred, causing the eyelashes to turn inwards and scratch the cornea (trichiasis), damaging the corneal surface and leading to corneal opacification and visual impairment. It is thought that this process is initiated and driven by repeated infection with Chlamydia trachomatis. We review published longitudinal studies to re-examine the disease process, its progression rates and risk factors. METHODOLOGY/PRINCIPAL FINDINGS: We searched PubMed for studies presenting incidence and progression data for the different stages of trachoma natural history. We only included studies reporting longitudinal data and identified 11 publications meeting this criterion. The studies were very heterogeneous in design, disease stage, duration, size and location, precluding meta-analysis. Severe conjunctival inflammation was consistently associated with incident and progressive scarring in five studies in which this was examined. One study reported an association between C. trachomatis infection and incident scarring. No studies have yet demonstrated an association between C. trachomatis infection and progressive scarring. Several studies conducted in regions with low prevalence active disease and C. trachomatis infection found evidence of on-going scarring progression. CONCLUSIONS/SIGNIFICANCE: Overall, there are few longitudinal studies that provide estimates of progression rates and risk factors, reflecting the challenges of conducting such studies. Our understanding of this disease process and the long-term impact of control measures is partial. Intense conjunctival inflammation was consistently associated with scarring, however, direct evidence demonstrating an association between C. trachomatis and progression is limited. This suggests that on-going chlamydial reinfection may not be mandatory for progression of established scarring, indicating that sight threatening trichiasis may continue to evolve in older people in formerly endemic populations, that will require service provision for years after active disease is controlled. Public Library of Science 2016-08-02 /pmc/articles/PMC4970760/ /pubmed/27483002 http://dx.doi.org/10.1371/journal.pntd.0004859 Text en © 2016 Ramadhani et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Ramadhani, Athumani M.
Derrick, Tamsyn
Holland, Martin J.
Burton, Matthew J.
Blinding Trachoma: Systematic Review of Rates and Risk Factors for Progressive Disease
title Blinding Trachoma: Systematic Review of Rates and Risk Factors for Progressive Disease
title_full Blinding Trachoma: Systematic Review of Rates and Risk Factors for Progressive Disease
title_fullStr Blinding Trachoma: Systematic Review of Rates and Risk Factors for Progressive Disease
title_full_unstemmed Blinding Trachoma: Systematic Review of Rates and Risk Factors for Progressive Disease
title_short Blinding Trachoma: Systematic Review of Rates and Risk Factors for Progressive Disease
title_sort blinding trachoma: systematic review of rates and risk factors for progressive disease
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4970760/
https://www.ncbi.nlm.nih.gov/pubmed/27483002
http://dx.doi.org/10.1371/journal.pntd.0004859
work_keys_str_mv AT ramadhaniathumanim blindingtrachomasystematicreviewofratesandriskfactorsforprogressivedisease
AT derricktamsyn blindingtrachomasystematicreviewofratesandriskfactorsforprogressivedisease
AT hollandmartinj blindingtrachomasystematicreviewofratesandriskfactorsforprogressivedisease
AT burtonmatthewj blindingtrachomasystematicreviewofratesandriskfactorsforprogressivedisease